Gotham Asset Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Sell |
45,332
-1,403
| -3% | -$50.5K | 0.01% | 994 |
|
|
2025
Q1 | $1.84M | Sell |
46,735
-4,214
| -8% | -$166K | 0.02% | 827 |
|
|
2024
Q4 | $1.53M | Sell |
50,949
-64,333
| -56% | -$1.94M | 0.01% | 782 |
|
|
2024
Q3 | $2.7M | Buy |
115,282
+41,975
| +57% | +$982K | 0.03% | 652 |
|
|
2024
Q2 | $1.3M | Buy |
73,307
+1,731
| +2% | +$30.8K | 0.02% | 808 |
|
|
2024
Q1 | $1.09M | Sell |
71,576
-24,674
| -26% | -$375K | 0.02% | 821 |
|
|
2023
Q4 | $1.64M | Buy |
96,250
+24,827
| +35% | +$424K | 0.03% | 670 |
|
|
2023
Q3 | $597K | Sell |
71,423
-59,271
| -45% | -$496K | 0.01% | 927 |
|
|
2023
Q2 | $3.25M | Buy |
130,694
+9,807
| +8% | +$244K | 0.07% | 393 |
|
|
2023
Q1 | $1.82M | Sell |
120,887
-5,555
| -4% | -$83.5K | 0.04% | 547 |
|
|
2022
Q4 | $1.5M | Buy |
+126,442
| New | +$1.5M | 0.04% | 531 |
|
|
2021
Q2 | – | Sell |
-10,756
| Closed | -$518K | – | 1101 |
|
|
2021
Q1 | $518K | Sell |
10,756
-22,960
| -68% | -$1.11M | 0.02% | 674 |
|
|
2020
Q4 | $1.75M | Buy |
33,716
+16
| +0% | +$832 | 0.06% | 385 |
|
|
2020
Q3 | $902K | Sell |
33,700
-11,088
| -25% | -$297K | 0.03% | 565 |
|
|
2020
Q2 | $872K | Buy |
+44,788
| New | +$872K | 0.03% | 591 |
|
|
2019
Q4 | – | Sell |
-11,105
| Closed | -$62K | – | 1211 |
|
|
2019
Q3 | $62K | Buy |
+11,105
| New | +$62K | ﹤0.01% | 1061 |
|